Healthcare leaders are no longer being asked simply whether they are exploring artificial intelligence. The more pressing questions are where AI is creating measurable value, who is accountable for its use and how organisations will protect trust as tools move beyond isolated experiments.
That transition is at the centre of the forthcoming second edition of AI in Health by Tom Lawry. For leaders looking for a Tom Lawry healthcare AI speaker, the relevance lies in this practical shift: moving from interest in the technology to disciplined decisions about implementation, investment, workforce readiness and patient-centred care.
From AI pilots to intelligent health systems
The new edition of AI in Health is positioned as a blueprint for creating value at scale and building intelligent health systems. In this context, an intelligent health system is not simply an organisation using a collection of AI tools. It is one that connects technology choices to clinical, operational and strategic priorities, with clear oversight of how those choices affect people and outcomes.
This distinction matters because a pilot can demonstrate technical possibility without establishing a sustainable operating model. Scaling requires leaders to address issues that can remain hidden during experimentation: data quality, workflow fit, governance, procurement, change management, workforce capability and measures of value.
For healthcare and life-sciences executives, the useful question is therefore not, “Where can we deploy AI?” It is, “What problem are we solving, what would responsible success look like, and how will we know?”
What healthcare leaders should do next with AI
Lawry’s focus on accountable AI leadership points to several practical conversations for executive teams. These are not a substitute for clinical, legal or technical judgement; they are organising questions that can help turn AI ambition into a governed programme of work.
- Set an explicit value case. Define the operational, clinical or service challenge before selecting a tool. Specify the measures that will indicate whether the initiative is worthwhile, as well as the conditions under which it should be adjusted or stopped.
- Assign accountability across disciplines. AI implementation is not solely an IT responsibility. Clinical leaders, operational owners, technology teams, risk functions and executives need clear roles in decisions, monitoring and escalation.
- Design for the workforce, not around it. New tools may change tasks, decision pathways and required skills. Leaders should consider training, adoption support and the practical effects on staff workloads from the outset.
- Make human-centred care a design requirement. Transparency, appropriate oversight and patient trust should be considered alongside efficiency and performance objectives. A technically capable system may still fail if clinicians or patients cannot understand its role or use it safely in real workflows.
How can AI create measurable value in healthcare?
Measurable value begins with a defined problem and a credible measurement approach. Depending on the use case, organisations may examine factors such as timeliness, service capacity, quality indicators, staff experience, cost or access. The appropriate measures will vary, but the principle is consistent: leaders need to distinguish an impressive demonstration from a result that can be sustained in a live health environment.
Investment discipline is especially important when organisations face competing priorities. Rather than treating AI as a standalone innovation agenda, leadership teams can evaluate initiatives against wider goals and make decisions about sequencing, resources and governance accordingly. This approach also creates a stronger basis for communicating with boards, clinicians, employees and other stakeholders about what an AI programme is intended to achieve.
Accountability is a leadership competency
The second edition’s emphasis on leadership frameworks, updated best practices and case studies reflects a broader need: healthcare AI requires leaders who can connect technology decisions with organisational responsibility. That includes asking difficult questions about who owns outcomes, how risks are monitored, when human review is needed and whether a system continues to serve the people it is meant to support.
For event audiences, this makes the discussion relevant well beyond digital teams. CEOs and health-system leaders can consider governance and investment choices; clinical and operational leaders can examine adoption and workflow realities; and pharma and medtech executives can explore how accountability should inform product, partnership and implementation decisions.
Why this topic belongs on healthcare event agendas
A keynote or leadership conversation with Lawry can give an audience a structured way to discuss the next stage of AI adoption: not technology hype, but the responsibilities that accompany deployment at scale. Suitable themes include healthcare AI accountability, intelligent health systems, value measurement, responsible implementation and workforce transformation.
For conference organisers, the strongest format is one that invites leaders to apply these questions to their own setting—whether a health system, life-sciences business, digital-health organisation or medtech company. The aim is not to prescribe one universal AI roadmap, but to clarify the leadership choices that determine whether innovation can be governed, adopted and assessed responsibly.
Frequently asked questions
What is healthcare AI accountability?
Healthcare AI accountability is the practice of assigning clear responsibility for AI decisions and outcomes. It includes governance, oversight, risk management, performance monitoring and transparency about how systems are used in care or operations.
How do organisations move beyond AI pilots?
They need a defined value case, measures of success, cross-functional ownership, workforce planning and governance that can operate beyond a limited trial. Scaling should follow evidence that a use case fits real workflows and can be monitored responsibly.
What should leaders measure in an AI initiative?
Measures should relate to the problem being addressed and may include service, operational, quality, access or workforce indicators. Leaders should also establish how they will monitor risks, adoption and whether the initiative remains appropriate over time.
To enquire about Tom Lawry for a conference, leadership meeting or corporate event, contact Speakers Connect at info@speakersconnect.com.